Labeler
Zydus Pharmaceuticals USA Inc. NDC Codes
Zydus Pharmaceuticals USA Inc. lists 629 finished drug products in the FDA NDC Directory under NDC labeler codes 68382, 70710.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Isotretinoin, Riociguat, brivaracetam, tofacitinib, Eltrombopag, Beizray, Carbidopa and Levodopa, Jaythari, Deflazacort, Ascorbic acid, gadobutrol, Verapamil hydrochloride, Diazepam, gabapentin, oxcarbazepine
- Active ingredients
- Deflazacort, Isotretinoin, Riociguat, Brivaracetam, Tofacitinib citrate, Eltrombopag olamine, Carbidopa, Levodopa, Ascorbic acid, Gadobutrol, Verapamil hydrochloride, Diazepam
- NDC labeler codes
- 68382, 70710
- Strengths (from the 100 most recently listed products)
- Ascorbic acid 500 mg/mL; Gadobutrol 604.72 mg/mL; Docetaxel anhydrous 20 mg/mL; Deflazacort 22.75 mg/mL; Deflazacort 6 mg/1; Deflazacort 18 mg/1; Deflazacort 30 mg/1; Deflazacort 36 mg/1; Riociguat .5 mg/1; Riociguat 1 mg/1; Riociguat 1.5 mg/1; Riociguat 2 mg/1; Riociguat 2.5 mg/1; Fluvoxamine maleate 100 mg/1; Fluvoxamine maleate 150 mg/1; Sugammadex sodium 200 mg/2mL; Sugammadex sodium 500 mg/5mL; Ranibizumab .3 mg/.05mL; Ranibizumab .5 mg/.05mL; Tofacitinib citrate 10 mg/1
- Dosage forms
- Tablet, Tablet, Film coated, Injection, Injection, Solution, Capsule, Capsule, Extended release, Kit, Gel, Tablet, Extended release, Tablet, Film coated, Extended release, Suspension, Liquid, Tablet, For suspension, Powder, For solution
- Routes
- Oral, Intravenous, Intramuscular, Subcutaneous, Rectal, Intravitreal
- Drug classes (FDA established)
- Corticosteroid, Serotonin Reuptake Inhibitor, Retinoid, Soluble Guanylate Cyclase Stimulator, Janus Kinase Inhibitor, Thrombopoietin Receptor Agonist, Aromatic Amino Acid, Anti-epileptic Agent, Vitamin C, Gadolinium-based Contrast Agent, Calcium Channel Blocker, Benzodiazepine, Angiotensin 2 Receptor Blocker, Neprilysin Inhibitor, Tetracycline-class Drug, Vascular Endothelial Growth Factor Inhibitor, Diagnostic Dye, Nitrogen Binding Agent, Sodium-Glucose Cotransporter 2 Inhibitor, Endothelin Receptor Antagonist, Microtubule Inhibitor, CCR5 Co-receptor Antagonist, Kinase Inhibitor, Calcitonin, Oxidation-Reduction Agent, Phosphate Binder, Xanthine Oxidase Inhibitor, Arteriolar Vasodilator, Enzyme Stabilizer, Glucosylceramide Synthase Inhibitor
- HCPCS / J-code
- J2778 — Injection, ranibizumab, 0.1 mg
- Package NDCs
- 169 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Cholestyramine | Cholestyramine 4 g/5.5g | Powder, For suspensionOral | 68382-529 | 68382-0529-4268382-0529-60 | — |
| budesonide | Budesonide 3 mg/1 | Capsule, Coated pelletsOral | 68382-720 | 68382-0720-0168382-0720-0568382-0720-06+3 more | — |
| acamprosate calcium | Acamprosate calcium 333 mg/1 | Tablet, Delayed releaseOral | 68382-569 | 68382-0569-0168382-0569-0568382-0569-06+3 more | — |
| tizanidine hydrochloride | Tizanidine hydrochloride 2 mg/1 | CapsuleOral | 70710-1111 | 70710-1111-0470710-1111-0570710-1111-08 | — |
| tizanidine hydrochloride | Tizanidine hydrochloride 4 mg/1 | CapsuleOral | 70710-1112 | 70710-1112-0470710-1112-0570710-1112-08 | — |
| tizanidine hydrochloride | Tizanidine hydrochloride 6 mg/1 | CapsuleOral | 70710-1113 | 70710-1113-0470710-1113-0570710-1113-08 | — |
| fluconazole | Fluconazole 50 mg/1 | TabletOral | 70710-1137 | 70710-1137-0170710-1137-0370710-1137-04+1 more | — |
| fluconazole | Fluconazole 100 mg/1 | TabletOral | 70710-1138 | 70710-1138-0170710-1138-0370710-1138-04+1 more | — |
| fluconazole | Fluconazole 150 mg/1 | TabletOral | 70710-1139 | 70710-1139-0170710-1139-0370710-1139-05+2 more | — |
| fluconazole | Fluconazole 200 mg/1 | TabletOral | 70710-1140 | 70710-1140-0170710-1140-0370710-1140-04+1 more | — |
| Minocycline hydrochloride | Minocycline hydrochloride 50 mg/1 | CapsuleOral | 68382-316 | 68382-0316-01 | — |
| Minocycline hydrochloride | Minocycline hydrochloride 75 mg/1 | CapsuleOral | 68382-317 | 68382-0317-01 | — |
| Minocycline hydrochloride | Minocycline hydrochloride 100 mg/1 | CapsuleOral | 68382-318 | 68382-0318-18 | — |
| Oseltamivir Phosphate | Oseltamivir phosphate 30 mg/1 | CapsuleOral | 70710-1008 | 70710-1008-02 | — |
| Oseltamivir Phosphate | Oseltamivir phosphate 45 mg/1 | CapsuleOral | 70710-1009 | 70710-1009-02 | — |
| Oseltamivir Phosphate | Oseltamivir phosphate 75 mg/1 | CapsuleOral | 70710-1010 | 70710-1010-02 | — |
| Methotrexate | Methotrexate 2.5 mg/1 | TabletOral | 68382-775 | 68382-0775-0168382-0775-0568382-0775-10+3 more | — |
| Nateglinide | Nateglinide 60 mg/1 | Tablet, Film coatedOral | 68382-721 | 68382-0721-0168382-0721-0568382-0721-06+3 more | — |
| Nateglinide | Nateglinide 120 mg/1 | Tablet, Film coatedOral | 68382-722 | 68382-0722-0168382-0722-0568382-0722-06+3 more | — |
| amantadine hydrochloride | Amantadine hydrochloride 100 mg/1 | CapsuleOral | 68382-512 | 68382-0512-0168382-0512-0568382-0512-06+1 more | — |
| glyburide | Glyburide 1.25 mg/1 | TabletOral | 68382-656 | 68382-0656-0168382-0656-0568382-0656-06+3 more | — |
| glyburide | Glyburide 2.5 mg/1 | TabletOral | 68382-657 | 68382-0657-0168382-0657-0568382-0657-06+3 more | — |
| glyburide | Glyburide 5 mg/1 | TabletOral | 68382-658 | 68382-0658-0168382-0658-0568382-0658-06+3 more | — |
| Glipizide and Metformin Hydrochloride | Glipizide 2.5 mg/1; Metformin hydrochloride 250 mg/1 | Tablet, Film coatedOral | 68382-184 | 68382-0184-0168382-0184-1068382-0184-16+1 more | — |
| Glipizide and Metformin Hydrochloride | Glipizide 2.5 mg/1; Metformin hydrochloride 500 mg/1 | Tablet, Film coatedOral | 68382-185 | 68382-0185-0168382-0185-1068382-0185-16+1 more | — |
| Glipizide and Metformin Hydrochloride | Glipizide 5 mg/1; Metformin hydrochloride 500 mg/1 | Tablet, Film coatedOral | 68382-186 | 68382-0186-0168382-0186-1068382-0186-16+1 more | — |
| glyburide and metformin hydrochloride | Glyburide 1.25 mg/1; Metformin hydrochloride 250 mg/1 | TabletOral | 68382-653 | 68382-0653-0168382-0653-0568382-0653-06+3 more | — |
| glyburide and metformin hydrochloride | Glyburide 2.5 mg/1; Metformin hydrochloride 500 mg/1 | TabletOral | 68382-654 | 68382-0654-0168382-0654-0568382-0654-06+3 more | — |
| glyburide and metformin hydrochloride | Glyburide 5 mg/1; Metformin hydrochloride 500 mg/1 | TabletOral | 68382-655 | 68382-0655-0168382-0655-0568382-0655-06+3 more | — |
| doxycycline | Doxycycline 75 mg/1 | CapsuleOral | 68382-706 | 68382-0706-0168382-0706-0568382-0706-06+4 more | — |
| doxycycline | Doxycycline 100 mg/1 | CapsuleOral | 68382-707 | 68382-0707-0168382-0707-0568382-0707-06+5 more | — |
| doxycycline | Doxycycline 50 mg/1 | CapsuleOral | 68382-782 | 68382-0782-0168382-0782-0568382-0782-06+4 more | — |
| pyridostigmine bromide | Pyridostigmine bromide 60 mg/1 | TabletOral | 68382-659 | 68382-0659-0168382-0659-0568382-0659-06+1 more | — |
| Metformin Hydrochloride | Metformin hydrochloride 500 mg/1 | Tablet, Film coatedOral | 68382-758 | 68382-0758-0168382-0758-0568382-0758-10+2 more | — |
| Metformin Hydrochloride | Metformin hydrochloride 850 mg/1 | Tablet, Film coatedOral | 68382-759 | 68382-0759-0168382-0759-0568382-0759-10+2 more | — |
| Metformin Hydrochloride | Metformin hydrochloride 1000 mg/1 | Tablet, Film coatedOral | 68382-760 | 68382-0760-0168382-0760-0568382-0760-10+2 more | — |
| acyclovir | Acyclovir 400 mg/1 | TabletOral | 68382-791 | 68382-0791-0168382-0791-0568382-0791-06+3 more | — |
| acyclovir | Acyclovir 800 mg/1 | TabletOral | 68382-792 | 68382-0792-0168382-0792-0568382-0792-06+3 more | — |
| telmisartan | Telmisartan 20 mg/1 | TabletOral | 68382-471 | 68382-0471-0168382-0471-0568382-0471-06+3 more | — |
| telmisartan | Telmisartan 40 mg/1 | TabletOral | 68382-472 | 68382-0472-0168382-0472-0568382-0472-06+3 more | — |
| telmisartan | Telmisartan 80 mg/1 | TabletOral | 68382-473 | 68382-0473-0168382-0473-0568382-0473-06+3 more | — |
| Potassium Citrate | Potassium citrate 5 meq/1 | Tablet, Extended releaseOral | 68382-536 | 68382-0536-0168382-0536-0568382-0536-06+3 more | — |
| Potassium Citrate | Potassium citrate 10 meq/1 | Tablet, Extended releaseOral | 68382-537 | 68382-0537-0168382-0537-0568382-0537-06+3 more | — |
| Potassium Citrate | Potassium citrate 15 meq/1 | Tablet, Extended releaseOral | 68382-538 | 68382-0538-0168382-0538-0568382-0538-06+3 more | — |
| Buspirone hydrochloride | Buspirone hydrochloride 5 mg/1 | TabletOral | 68382-180 | 68382-0180-0168382-0180-0568382-0180-10+1 more | — |
| Buspirone hydrochloride | Buspirone hydrochloride 10 mg/1 | TabletOral | 68382-181 | 68382-0181-0168382-0181-0568382-0181-10+1 more | — |
| Buspirone hydrochloride | Buspirone hydrochloride 15 mg/1 | TabletOral | 68382-182 | 68382-0182-0168382-0182-0568382-0182-10+3 more | — |
| Buspirone hydrochloride | Buspirone hydrochloride 30 mg/1 | TabletOral | 68382-183 | 68382-0183-0568382-0183-1068382-0183-14+1 more | — |
| Etodolac | Etodolac 400 mg/1 | Tablet, Film coated, Extended releaseOral | 68382-271 | 68382-0271-0168382-0271-0568382-0271-10+2 more | — |
| Etodolac | Etodolac 500 mg/1 | Tablet, Film coated, Extended releaseOral | 68382-272 | 68382-0272-0168382-0272-0568382-0272-10+2 more | — |
Zydus Pharmaceuticals USA Inc.: common questions
- What is Zydus Pharmaceuticals USA Inc.'s NDC labeler code?
- 68382, 70710. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Zydus Pharmaceuticals USA Inc.?
- Med-Code's HCPCS directory matches J2778 to these products. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.